Location History:
- Rixensart, BE (2004 - 2018)
- Bonnine, BE (2018)
Company Filing History:
2 out of 531 
1 out of 67 
1 out of 21 Years Active: 2004-2018
Title: Pierre Vandepapeliere: Innovator in Vaccine Development
Introduction
Pierre Vandepapeliere is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly in vaccine development. With a total of four patents to his name, Vandepapeliere's work focuses on enhancing vaccine efficacy through innovative adjuvant compositions.
Latest Patents
Vandepapeliere's latest patents include groundbreaking vaccine compositions that utilize a saponin adjuvant. These inventions provide a human dose of an immunogenic composition that combines an antigen or antigenic preparation with an adjuvant. The adjuvant comprises an immunologically active saponin fraction derived from the bark of Molina, presented in the form of a liposome, along with a lipopolysaccharide. Both components are present in the human dose at levels below 30 µg. This innovative approach aims to improve the immune response to vaccines.
Career Highlights
Throughout his career, Vandepapeliere has worked with prominent companies in the pharmaceutical industry. He has been associated with GlaxoSmithKline Biologicals SA and SmithKline Beecham Biologicals SA. His experience in these organizations has contributed to his expertise in vaccine research and development.
Collaborations
Vandepapeliere has collaborated with esteemed colleagues in the field, including Moncef Mohamed Slaoui and Geraldine Grouard-Vogel. These partnerships have furthered his research and innovation in vaccine technology.
Conclusion
Pierre Vandepapeliere is a distinguished inventor whose work in vaccine development has the potential to significantly impact public health. His innovative approaches to adjuvant compositions demonstrate his commitment to advancing immunology.